“Smart” Proteins Poised to Revolutionize Targeted drug Delivery with Advanced Biomarker Recognition
Table of Contents
A groundbreaking advance in synthetic biology is bringing scientists closer to creating “smart” drugs capable of delivering therapies with unprecedented precision, potentially transforming treatment for diseases like cancer. Researchers at the University of Washington have engineered proteins with autonomous decision-making capabilities, allowing them to target specific areas of the body based on unique combinations of environmental cues.
the Challenge of Targeted Therapies
targeted drug delivery – the ability to deliver medication directly to diseased tissues while sparing healthy cells – holds immense promise for reducing side effects and improving treatment efficacy. For example, a targeted immunotherapy could activate the immune system to fight cancer cells exclusively within a tumor, minimizing damage to other parts of the body.However, creating therapies that can accurately identify and reach their intended targets has proven remarkably challenging. The key lies in developing systems that can intelligently navigate the body and “decide” where to act.
Programming Proteins with “Smart” Tails
Published October 9 in Nature Chemical Biology, the University of washington team’s research details a novel approach: adding specially designed “tail” structures to proteins that respond to specific biomarkers. These “tails” are engineered using Boolean logic – a system of logical operations traditionally used in computer programming – to create materials that responded to multiple biomarkers. “We realized that we could program how therapeutics were released based simply on how they were connected to a carrier material,” DeForest said. The team initially used “OR” and “AND” gates to control drug release, but scaling up production proved challenging.
A important breakthrough came with advances in synthetic biology. New protein-based tools enabled the formation of permanent bonds between proteins, opening doors to more complex structures and logical operations. Crucially, scientists could now leverage living cells as miniature factories to produce these complex proteins, designing DNA blueprints and collecting the resulting proteins directly from the cells.
A five-Biomarker Future
This streamlined process has dramatically reduced production time and cost. Where previously synthesizing a few milligrams of a material could take months, the team can now achieve the same result in a matter of weeks. The new proteins can respond to up to five different biomarkers, attaching to various carriers for delivery. In one experiment, researchers loaded a single carrier with three different proteins, each programmed to deliver its unique cargo based on distinct environmental cues.
“Using the old process, it would take months to synthesize just a few milligrams of each of these materials. now it takes us a couple of weeks to go from construct design to product. It’s been a complete game changer for us,” DeForest stated. Murial Ross, a UW doctoral student of bioengineering and co-first author, added, “The sky’s the limit. You can create delayed and independent delivery of many different components in one treatment.”
Beyond Cancer: Diagnostic Tools and Cellular Therapies
The researchers are now focused on identifying additional biomarkers that proteins can target and collaborating with other labs to translate this technology into real-world therapies. The potential applications extend beyond cancer treatment. The same tools could be used to manufacture therapies within individual cells, directing them to specific regions. DeForest also envisions diagnostic tools, such as blood tests that change color in response to a complex set of biomarkers.
“The dream is to be able to pick any arbitrary location inside of the body – down to individual cells – and program a material to go and act there,” DeForest concluded. “That’s a tall order, but with these technologies we’re getting closer. With the right combination of biomarkers, these materials will just get more and more precise.”
Source: Journal reference: Gharios, R., et al. (2025) Boolean logic-gated protein presentation through autonomously compiled molecular topology. Nature Chemical Biology. doi.org/10.1038/s41589-025-02037-5.
